Overall, the results support that the mechanisms of IL13Rα2-triggered cancer progression are relatively homogenous, with minor differences likely caused by the different genetic background (i.e. APC mutations in CRC). The gene discussed is IL13RA2; the disease is colorectal carcinoma.